Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination
Mathieu Surénaud, Matthieu Montès, Cecilia S. Lindestam Arlehamn, et al.
PLoS Pathogens (2019) Vol. 15, Iss. 9, pp. e1008011-e1008011
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Enhanced antigen-specific CD8 T cells contribute to early protection against FMDV through swine DC vaccination
Suyu Mu, Lingbo Chen, Hu Dong, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access | Times Cited: 9
Epitope prediction and identification- adaptive T cell responses in humans
John Sidney, Bjoern Peters, Alessandro Sette
Seminars in Immunology (2020) Vol. 50, pp. 101418-101418
Open Access | Times Cited: 51
Potency assays and biomarkers for cell-based advanced therapy medicinal products
Chiara Capelli, Carolina Cuofano, Chiara Pavoni, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Therapeutic Vaccines for the Treatment of HIV
Zhilin Chen, Boris Jülg
Translational research (2020) Vol. 223, pp. 61-75
Open Access | Times Cited: 32
New Approaches to Dendritic Cell-Based Therapeutic Vaccines Against HIV-1 Infection
María de la Sierra Espinar-Buitrago, María Ángeles Muñoz‐Fernández
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 16
Viral T-cell epitopes – Identification, characterization and clinical application
Sarah M. Schroeder, Annika Nelde, Juliane S. Walz
Seminars in Immunology (2023) Vol. 66, pp. 101725-101725
Closed Access | Times Cited: 10
Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be Ex Vivo?
Jonny Jonny, Terawan Agus Putranto, Enda Cindylosa Sitepu, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 8, pp. 1111-1120
Open Access | Times Cited: 16
Refining the DC-targeting vaccination for preventing emerging infectious diseases
Yadira Pastor, Nour Ghazzaui, Adele Hammoudi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials
Elahe Akbari, Masoud Seyedinkhorasani, Azam Bolhassani
The Brazilian Journal of Infectious Diseases (2023) Vol. 27, Iss. 3, pp. 102774-102774
Open Access | Times Cited: 7
In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes
Elahe Akbari, Kimia Kardani, Ali Namvar, et al.
Biotechnology Letters (2021)
Open Access | Times Cited: 16
The quest for faithful in vitro models of human dendritic cells types
Xinlong Luo, Marc Dalod
Molecular Immunology (2020) Vol. 123, pp. 40-59
Open Access | Times Cited: 16
Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill
Jan Kristoff, Charles R. Rinaldo, Robbie B. Mailliard
Viruses (2019) Vol. 12, Iss. 1, pp. 37-37
Open Access | Times Cited: 15
Dendritic Cells in HIV/SIV Prophylactic and Therapeutic Vaccination
Eun‐Ju Ko, Marjorie Robert-Guroff
Viruses (2019) Vol. 12, Iss. 1, pp. 24-24
Open Access | Times Cited: 15
Nanoparticle-Delivered HIV Peptides to Dendritic Cells a Promising Approach to Generate a Therapeutic Vaccine
Alba Martín-Moreno, José L. Jiménez Blanco, Jamie Mosher, et al.
Pharmaceutics (2020) Vol. 12, Iss. 7, pp. 656-656
Open Access | Times Cited: 12
A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial
Yves Lévy, Christine Lacabaratz, Édouard Lhomme, et al.
Journal of Virology (2021) Vol. 95, Iss. 9
Open Access | Times Cited: 11
Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine
Mona Sadat Larijani, Amitis Ramezani, Maryam Mashhadi Abolghasem Shirazi, et al.
Virus Research (2021) Vol. 298, pp. 198403-198403
Open Access | Times Cited: 11
A mathematical model for HIV dynamics with multiple infections: implications for immune escape
Qi Deng, Ting Guo, Zhipeng Qiu, et al.
Journal of Mathematical Biology (2024) Vol. 89, Iss. 1
Closed Access | Times Cited: 1
Dendritic cells in the treatment of HIV, cancer and systemic lupus erythematosus
Lenin Leonardo Bravo-Martínez, Moisés Talavera-Paulin
Proceedings of Scientific Research Universidad Anáhuac Multidisciplinary Journal of Healthcare (2024) Vol. 4, Iss. 7, pp. 23-33
Open Access | Times Cited: 1
The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook
Hager Mohamed, Vandana Miller, Stephen R. Jennings, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 11
Targeting human langerin promotes HIV-1 specific humoral immune responses
Jérôme Kervevan, Aurélie Bouteau, Juliane S. Lanza, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 7, pp. e1009749-e1009749
Open Access | Times Cited: 9
Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial
Marcella Vassão de Almeida Baptista, Laís Teodoro da Silva, Sadia Samer, et al.
AIDS Research and Therapy (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Dendritic Cells - Winning the Fight against HIV
Mohsen Sheykhhasan, Naresh Poondla, Yaghoub Ahmadyousefi, et al.
Current Stem Cell Research & Therapy (2022) Vol. 18, Iss. 2, pp. 174-185
Closed Access | Times Cited: 4
Elevated HIV Infection of CD4 T Cells in MRKAd5 Vaccine Recipients Due to CD8 T Cells Targeting Adapted Epitopes
Kai Qin, Sushma Boppana, Jonathan M. Carlson, et al.
Journal of Virology (2021) Vol. 95, Iss. 16
Open Access | Times Cited: 4
Inhibition of the antigen-presenting ability of dendritic cells by non-structural protein 2 of influenza A virus
Jian Lin, Yanan Cao, Abid Ullah Shah, et al.
Veterinary Microbiology (2022) Vol. 267, pp. 109392-109392
Closed Access | Times Cited: 3
DENDRITIC CELLS AS AN IMMUNOTHERAPY TOOL
Helen Fernanda Marcelino Pacheco, Maria Laura Faria de Andrade, Bruna Santana Silva Pinheiro, et al.
Acta Biologica Brasiliensia. (2024) Vol. 7, Iss. 1, pp. 6-19
Open Access
Page 1 - Next Page

Scroll to top